OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
Article
Knop, S, Hebart, H, Gscheidle, H, Holler, E, Kolb, H-J, Niederwieser, D and Einsele, H (2005) OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplantation 36 (9), pp. 831-837.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Bone Marrow Transplantation | ||||
| Publisher | NATURE PUBLISHING GROUP | ||||
| Place of Publication | LONDON | ||||
| Volume | 36 | ||||
| Number of Issue or Book Chapter | 9 | ||||
| Page Range | pp. 831-837 | ||||
| Date | 2005 | ||||
| Date of publication | 19 Dec 2024 14:55 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | BONE-MARROW-TRANSPLANTATION; ANTI-THYMOCYTE GLOBULIN; MONOCLONAL-ANTIBODIES; ACUTE GVHD; LYMPHOPROLIFERATIVE DISORDER; ANTITHYMOCYTE GLOBULIN; THERAPY; LYMPHOCYTES; DONORS; stem cell transplantation; graft-versus-host disease; monoclonal antibody; OKT3 | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 70380 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric